Clinical Trials on Perinatal Mortality in Argentina

Total 13 results

Begona Martinez de Tejada
Hospital Italiano de Buenos Aires; University of Zurich; University Hospital... and other collaborators

Terminated

Vaginal Progesterone to Prevent Preterm Delivery in Women With Preterm Labor (4P)

Preterm Delivery | Morbidity | Perinatal Mortality

Switzerland, Argentina
Hospital Italiano de Buenos Aires

Unknown

Non Attendance at Scheduled Appointments as a Marker of Mortality and Hospital Admission

Mortality | Hospitalization | Emergency Department | Appointments and Schedules | Outpatient Clinics, Hospital/Economics

Argentina
NICHD Global Network for Women's and Children's...

Completed

Emergency Obstetric and Neonatal Care: The EmONC Trial (EmONC)

Maternal Morbidity and Mortality | Stillbirth and Neonatal Mortality

Zambia, India, Pakistan, Kenya, Guatemala, Argentina
Hospital Italiano de Buenos Aires

Completed

Bacterial Infections in Patients With Cirrhosis in Argentina: Clinical and Microbiological Characteristics

Bacterial Infections | Cirrhosis | Morality | Resistant Infection

Argentina
Hospital de Clinicas José de San Martín

Recruiting

Usefulness of Wireless pH Monitoring in GERD Diagnosis

Gastroesophageal Reflux

Argentina
Hospital Privado de Comunidad de Mar del Plata
Austral University, Argentina; Hospital Aleman

Recruiting

Characteristics and Outcomes of Patients With COVID-19 Treated With High-flow Nasal Oxygen and Awake-prone Position (AW-PP_Covid)

COVID-19 | Mortality | Endotracheal Intubation | Respiratory Failure | Prone Position

Argentina
AstraZeneca

Completed

A Study of Nexium (Esomeprazole) 40 mg Once Daily in Subjects With Symptoms of Gastroesophageal Reflux Disease (GORD) After Treatment With a Full Dose of Proton Pump Inhibitor (PPI) (NEON)

Gastroesophageal Reflux Disease

Chile, Argentina, Venezuela, Colombia
Pfizer

Terminated

PREA, PK And Safety PASS Study Of IV Pantoprazole In Pediatric Subjects

Gastroesophageal Reflux Disease

United States, Bosnia and Herzegovina, Slovakia, Italy, Germany, Argentina, Georgia, Serbia, Ukraine
Eisai Inc.

Completed

Rabeprazole Extended-Release, 50 mg, Versus Esomeprazole, 40 mg, for Healing and Symptomatic Relief of Moderate to Severe Erosive Gastroesophageal Reflux Disease (GERD)

Gastroesophageal Reflux Disease (GERD)

Chile, Canada, United States, Estonia, India, Hungary, Bulgaria, Croatia, Australia, Lithuania, Latvia, Argentina, France, Germany
Eisai Inc.

Completed

Rabeprazole Extended-Release 50 mg Versus Esomeprazole 40 mg for Healing and Symptomatic Relief of Moderate to Severe Erosive Gastroesophageal Reflux Disease (GERD)

Gastroesophageal Reflux Disease (GERD)

Canada, Chile, Hungary, Bulgaria, Estonia, Latvia, United States, Croatia, Australia, India, Argentina, France, Germany
AstraZeneca

Completed

National Survey on GERD Patients (Adults and Children) (RGO à trav)

GERD (Gastroesophageal Reflux Disease)

France
Takeda

Completed

Effect of Pantoprazole on the Symptoms of Acid Reflux Disease in Adult Patients (BY1023/M3-341)

Gastroesophageal Reflux Disease (GERD)

United Kingdom, Australia, Belgium, Spain, Austria, Germany, Argentina, Brazil, Canada, France, Hong Kong, India, Italy, Korea, Republic of, Malaysia, Mexico, Poland, Portugal, Singapore, South Africa, Switzerland, Taiwan
Erasmus Medical Center

Active, not recruiting

International Guillain-Barré Syndrome Outcome Study (IGOS)

Guillain-Barré Syndrome | Miller Fisher Syndrome

United States, Netherlands, United Kingdom, Bangladesh, Australia, Denmark, China, France, Germany, Spain, Argentina, Italy, Puerto Rico, South Africa, Belgium, Switzerland, Canada, Greece, Japan, Malaysia, Taiwan

Clinical Trials on Perinatal Mortality in Argentina

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in France

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations